Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Am J Ophthalmol. 2017 Jan 17;176:102–107. doi: 10.1016/j.ajo.2017.01.004

Table 5.

Quality of life measures showing Visual Function Questionairre-25 scores by group at six and 12 months.

Group VFQ-25 score St Dev VFQ improvement P value
ACZ to open-label ACZ 91.95 8.75
91.64 6.03 −0.31 0.78
PLB to open-label ACZ 86.05 12.27
88.64 10.7 2.59 0.01
ACZ tapered off ACZ 93.13 8.60
93.69 7.78 056 0.82
PLB to no ACZ 92.36 6.21
94.27 2.20 1.92 0.2

ACZ = acetazolamide, PLB = placebo, VFQ = Visual Function Questionairre